Sort
23,748 grants matching “melanoma”
Mutagenic chain reaction-facilitated immunotherapy
$651,000Stephen M Hedrick · University Of California, San Diego · R01 · FY2017 · AI
Mutagenic chain reaction-facilitated immunotherapy
$651,000Stephen M Hedrick · University Of California, San Diego · R01 · FY2020 · AI
Mutagenic chain reaction-facilitated immunotherapy
$651,000Stephen M Hedrick · University Of California, San Diego · R01 · FY2019 · AI
Mutagenic chain reaction-facilitated immunotherapy
$651,000Stephen M Hedrick · University Of California, San Diego · R01 · FY2016 · AI
MACROPHAGE-CENTRIC PROGNOSTIC BIOMARKERS FOR CHECKPOINT BLOCKADE IMMUNOTHERAPY IN MELANOMA
$650,845University Of Alabama At Birmingham · · FY2025 · Defense Health Agency
Ms. LILAC: Muscle Mass in the Life and Longevity After Cancer (LILAC) Study
$650,821Hailey Rose Banack · State University Of New York At Buffalo · R37 · FY2024 · CA
(PQ#3) Novel tumor intrinsic PD-L1 signals direct tumor immune cell infiltration
$650,815Tyler J. Curiel · University Of Texas Hlth Science Center · R01 · FY2017 · CA
Controlling Tumor Immune Escape in Pancreatic Cancer using a Dual T Cell Product Strategy
$650,671Juan Fernando Vera · Marker Therapeutics, Inc. · R44 · FY2024 · CA
Steady states and cellular transitions associated with carcinogenesis and tumorprogression
$650,589James R. Heath · Institute For Systems Biology · U01 · FY2019 · CA
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
$650,522Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
Regulation of resistance to CDK4/6 inhibitor in breast cancer
$650,485Wenge Zhu · George Washington University · R01 · FY2023 · CA
Novel molecular imaging approaches to monitor gene and cell-based therapies
$650,363Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2011 · CA
YALE SKIN DISEASES RESEARCH CORE CENTER
$650,333Yale University · P30 · FY2000 · AR
(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer
$650,064Anna Karolina Palucka · Jackson Laboratory · R01 · FY2019 · CA
New tools for tracking single cells in vivo
$650,016Guillem Pratx · Stanford University · R01 · FY2020 · EB
Canine models for characterization, diagnosis, and treatment of human cancers using comparative canine-human transcriptomics
$650,000Gregory Tawa · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Toward translation of a plant virus-based in situ vaccination nanotechnology
$649,918Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2022 · CA
Modulating T cell tolerance to elicit tumor immunity and autoimmunity
$649,750Arthur Andrew Hurwitz · Basic Sciences · Z01 · FY2007 · CA
Natural Language Processing Platform for Cancer Surveillance
$649,667Guergana K. Savova · Boston Children'S Hospital · UH3 · FY2022 · CA
A Registry-Based Study of Patterns of Use of Targeted Therapies for Metastatic Cancers in Diverse Populations
$649,510Christine Veenstra · University Of Michigan At Ann Arbor · R37 · FY2022 · CA
Atherosclerosis, Prostaglandin Inhibition and Checkpoint Blockade
$649,492Garret A Fitzgerald · University Of Pennsylvania · R01 · FY2020 · HL
Confocal video-mosaicking microscopy to guide surgery of superficially spreading skin cancers
$649,426Milind Rajadhyaksha · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Imaging Acidosis and Immune Therapy in PDAC
$649,329Shari Pilon-Thomas · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy
$648,963Richard J Price · University Of Virginia · R01 · FY2021 · EB
Targeting tumoral Lactobacillus iners to improve outcomes in cervical cancers
$648,677Lauren Elizabeth Colbert · University Of Tx Md Anderson Can Ctr · R37 · FY2025 · CA